News
Tylenol, Kenvue
Digest more
The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, ...
Echoing this, short-term traders are also sporting a call-bias. This is per the security's Schaeffer's put/call open interest ...
The maker of Tylenol and Benadryl named director Kirk Perry as interim chief executive. Shares rallied over 5% before t ...
With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...
Nestled among the overflowing buffet of Tylenol products at your local pharmacy is Tylenol 8 Hour — the extended-release ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback